The main point is how your policy impact the quality of patient care.
Consider a life-threatening situation in an acute care setting. How does
the patient benefit (or suffer) from the policy?
How does (would) your policy stand up in court? What is the opinion of
the legal consultant for the facility?
Is the policy consistent with guidelines of the accreditation or
regulatory body?
> Re:-
>>I would be interested to know policies individual laboratories have in
> ...etc
>
>The agreed policy here is to NOT analyse ANY unlabelled samples.
>NOR if poorly labelled with equivocal id.
>
>The requesting doctor is phoned if possible, otherwise message given.
>It is recorded in the Pathology Computer, using id of the intended
patient.
>
>Experienced Consultants & GP's do agree with this policy, even if
others of
>lesser experience don't.
>
>
>Dr Les Culank,
>Consultant Chemical Pathologist.
>Dept of Clinical Biochemistry, Addenbrooke's Hospital
>Cambridge UK CB2 2QR
>Tel: +44 (0)1223.217153 fax: 216862
>
>
>
______________________________________________________
Get Your Private, Free Email at http://www.hotmail.com
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
|